Brooklyn ImmunoTherapeutics Announces Changes to Executive Management: Matt Angel, Ph.D. Appointed Interim Chief Executive Officer and President, Andrew Jackson Appointed Chief Financial Officer Postpones 2022 Annual Meeting

3 years ago

SAN DIEGO, May 31, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn” or the “Company”), a biopharmaceutical company focused…

Altimmune to Present Pemvidutide Clinical Data at Upcoming American Diabetes Association Scientific Sessions June 6, 2022

3 years ago

GAITHERSBURG, Md., May 31, 2022 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr.…

Jushi Holdings Inc. Announces Participation in Upcoming Conference and Event in June 2022

3 years ago

BOCA RATON, Fla., May 31, 2022 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF),…

TG Therapeutics Announces FDA Extension of BLA PDUFA Date for Ublituximab to Treat Patients with RMS

3 years ago

New PDUFA goal date of December 28, 2022NEW YORK, May 31, 2022 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today…

Bloom Health Partners Reports Profitable Fiscal Q2 2022 with $11.1 Million in Revenue

3 years ago

Vancouver, British Columbia--(Newsfile Corp. - May 31, 2022) - Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom"…

LevelJump Announces Record Revenues from Operations; Q1 Revenue Increase of 27%; Q1 2022 Earnings and Results

3 years ago

Toronto, Ontario--(Newsfile Corp. - May 31, 2022) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the…

Lophos Pharmaceuticals Corp. CEO Claire Stawnyczy Presenting at O’Cannabiz Psychedelics Summit – June 2nd

3 years ago

Napanee, Ontario--(Newsfile Corp. - May 31, 2022) - Lophos Pharmaceuticals Corp., a Canadian biosciences research and development company that focuses…

Stryker Receives FDA Clearance for Q Guidance System for Spine Applications

3 years ago

Innovative planning and intraoperative platform designed to be a procedural ecosystem for surgeons and their patients during image-guided surgery KALAMAZOO,…

Perimeter Medical Imaging AI Reports First Quarter 2022 Financial Results and Provides Corporate Update

3 years ago

Conference Call/Webcast on Wednesday, June 1, 2022 at 5 pm ET TORONTO & DALLAS--(BUSINESS WIRE)--$PINK.V #AI--Perimeter Medical Imaging AI, Inc.…

Mana Capital Acquisition Corp. and Cardio Diagnostics, Inc. Announce Definitive Business Combination Agreement to Create Publicly Listed Company Set to Transform Cardiovascular Disease Through Epigenetics

3 years ago

Cardio Diagnostics, Inc. has pioneered a proprietary artificial intelligence-driven Integrated Genetic-Epigenetic Engine™ that enables improved diagnosis and prevention of cardiovascular…